{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:01:09Z","timestamp":1767837669836,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["0887X1-4603"],"award-info":[{"award-number":["0887X1-4603"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.vaccine.2015.01.030","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:18:04Z","timestamp":1421713084000},"page":"1135-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Early impact of PCV7\/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study"],"prefix":"10.1016","volume":"33","author":[{"given":"Gili","family":"Regev-Yochay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Paran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad","family":"Bishara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Oren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Chowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgenia","family":"Tziba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Istomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Miron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Temper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2015.01.030_bib0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.030_bib0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.030_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997\u20132007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2015.01.030_bib0135","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/652440","article-title":"The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes","volume":"50","author":"Lehmann","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2015.01.030_bib0140","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2012.06.068","article-title":"Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children","volume":"30","author":"van der Linden","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.01.030_bib0145","first-page":"387","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"Respiratory medicine"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.030_bib0150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/infdis\/jiu213","article-title":"Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England","volume":"Oct 1; 210","author":"Moore","year":"2014","journal-title":"J Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2015.01.030_bib0155","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"32","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2015.01.030_bib0160","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.vaccine.2013.02.059","article-title":"A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7","volume":"31","author":"Regev-Yochay","year":"2013","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2015.01.030_bib0165","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the national immunization plan in Israel","volume":"30","author":"Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.030_bib0170","doi-asserted-by":"crossref","first-page":"e88406","DOI":"10.1371\/journal.pone.0088406","article-title":"Initial effects of the national PCV7 childhood immunization program on adult invasive pneumococcal disease in Israel","volume":"9","author":"Regev-Yochay","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.030_bib0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2015.01.030_bib0180","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","article-title":"Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme","volume":"28","author":"Harboe","year":"2010","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2015.01.030_bib0185","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.vaccine.2014.07.060","article-title":"Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study","volume":"32","author":"Meichtry","year":"2014","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2015.01.030_bib0190","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2014.04.066","article-title":"European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era","volume":"32","author":"Torne","year":"2014","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2015.01.030_bib0195","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.030_bib0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2015.01.030_bib0205","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.030_bib0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2015.01.030_bib0215","doi-asserted-by":"crossref","first-page":"e73704","DOI":"10.1371\/journal.pone.0073704","article-title":"The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5","volume":"8","author":"Horacio","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.030_bib0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/cir354","article-title":"The spectrum of pneumococcal empyema in adults in the early 21st century","volume":"53","author":"Burgos","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2015.01.030_bib0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.030_bib0230","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004\u20132005","volume":"48","author":"Richter","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:09Z","timestamp":1759400469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0264410X15000493"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early impact of PCV7\/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}